Annual Accounts Payable
$141.00 K
-$956.00 K-87.15%
December 31, 2023
Summary
- As of March 11, 2025, FNCH annual accounts payable is $141.00 thousand, with the most recent change of -$956.00 thousand (-87.15%) on December 31, 2023.
- During the last 3 years, FNCH annual accounts payable has fallen by -$2.48 million (-94.62%).
- FNCH annual accounts payable is now -96.23% below its all-time high of $3.74 million, reached on December 31, 2021.
Performance
FNCH Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$29.00 K
-$18.00 K-38.30%
June 30, 2024
Summary
- As of March 11, 2025, FNCH quarterly accounts payable is $29.00 thousand, with the most recent change of -$18.00 thousand (-38.30%) on June 30, 2024.
- Over the past year, FNCH quarterly accounts payable has stayed the same.
- FNCH quarterly accounts payable is now -99.39% below its all-time high of $4.76 million, reached on March 31, 2022.
Performance
FNCH Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
FNCH Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -87.2% | 0.0% |
| 3 y3 years | -94.6% | 0.0% |
| 5 y5 years | -78.5% | 0.0% |
FNCH Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -96.2% | at low | -99.4% | at low |
| 5 y | 5-year | -96.2% | at low | -99.4% | at low |
| alltime | all time | -96.2% | at low | -99.4% | at low |
Finch Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $29.00 K(-38.3%) |
| Mar 2024 | - | $47.00 K(-66.7%) |
| Dec 2023 | $141.00 K(-87.1%) | $141.00 K(-60.5%) |
| Sep 2023 | - | $357.00 K(-17.4%) |
| Jun 2023 | - | $432.00 K(-83.1%) |
| Mar 2023 | - | $2.55 M(+132.7%) |
| Dec 2022 | $1.10 M | $1.10 M(+3.5%) |
| Sep 2022 | - | $1.06 M(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.01 M(-78.7%) |
| Mar 2022 | - | $4.76 M(+27.5%) |
| Dec 2021 | $3.74 M(+42.6%) | $3.74 M(+170.4%) |
| Sep 2021 | - | $1.38 M(-19.6%) |
| Jun 2021 | - | $1.72 M(-55.7%) |
| Mar 2021 | - | $3.88 M(+48.0%) |
| Dec 2020 | $2.62 M(+300.2%) | $2.62 M |
| Dec 2019 | $655.00 K | - |
FAQ
- What is Finch Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Finch Therapeutics?
- What is Finch Therapeutics annual accounts payable year-on-year change?
- What is Finch Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Finch Therapeutics?
- What is Finch Therapeutics quarterly accounts payable year-on-year change?
What is Finch Therapeutics annual accounts payable?
The current annual accounts payable of FNCH is $141.00 K
What is the all time high annual accounts payable for Finch Therapeutics?
Finch Therapeutics all-time high annual accounts payable is $3.74 M
What is Finch Therapeutics annual accounts payable year-on-year change?
Over the past year, FNCH annual accounts payable has changed by -$956.00 K (-87.15%)
What is Finch Therapeutics quarterly accounts payable?
The current quarterly accounts payable of FNCH is $29.00 K
What is the all time high quarterly accounts payable for Finch Therapeutics?
Finch Therapeutics all-time high quarterly accounts payable is $4.76 M
What is Finch Therapeutics quarterly accounts payable year-on-year change?
Over the past year, FNCH quarterly accounts payable has changed by $0.00 (0.00%)